O6-Methylguanine-DNA methyltransferase activity in human tumors

Abstract

The distribution of O⁶-methylguanine-DNA methyltransferase (MGMT) activity in extracts of tumors from 74 patients was measured. The results demonstrated that there was considerable variation of MGMT activity in different human tumor tissues as well as in different individuals. The mean values (⁠ $X¯±SD$⁠, pmol/mg of protein) in breast cancer, stomach cancer, small cell lung cancer, non-small cell lung cancer, renal cell carcinoma, esophageal carcinoma, brain tumors, colon carcinoma and malignant melanoma were 1.071 ± 0.374 (9), 0.515 ± 0.107 (5), 0.509 ± 0.251 (5), 0.461 ± 0.227 (24), 0.329 ± 0.246 (5), 0.273 ± 0.376 (5), 0.244 ± 0.175 (14), 0.242 ± 0.308 (5) and 0.201 ± 0.161 (2) respectively. It was notable that six samples (1/24 non-small cell lung cancer, 3/5 esophageal carcinoma, 1/14 brain tumors and 1/5 colon carcinoma) did not have any detectable level of MGMT activity. Activity of glutamine pyruvic transaminase (GPT) was also measured in the same extracts used for the assay of MGMT activity. The activity of GPT in these samples with undectectable level of MGMT activity was similar to those with significant MGMT activity. These results further strengthen the assumption that a certain fraction of human tumors are Mer⁻.